NCT01626534View on ClinicalTrials.gov

Evaluation of Ticagrelor Anti Platelet and Pleiotropic Effects in Patients Undergoing Percutaneous Coronary Intervention for an Acute Coronary Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Acute Coronary Syndrome
Interventions
DRUG

Clopidogrel

600mg loading dose then 75mg/day

DRUG

trigagrelor

180 mg loading dose then 90 mg Twice a day

Trial Locations (1)

13354

Assistance Publique Hopitaux de Marseille, Marseille

All Listed Sponsors
lead

Assistance Publique Hopitaux De Marseille

OTHER

NCT01626534 - Evaluation of Ticagrelor Anti Platelet and Pleiotropic Effects in Patients Undergoing Percutaneous Coronary Intervention for an Acute Coronary Syndrome | Biotech Hunter | Biotech Hunter